Intrinsic Value of S&P & Nasdaq Contact Us

Affimed N.V. AFMD NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • DE • USD

SharesGrow Score
43/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$7.50
+4032.2%

Financial Health Score — AFMD

Affimed N.V. (AFMD) has an overall financial health rating of D+ with a composite score of 1 out of 5.

Component scores: Discounted Cash Flow (DCF): 1/5, Return on Equity (ROE): 1/5, Return on Assets (ROA): 1/5, Debt-to-Equity (D/E): 1/5, Price-to-Earnings (P/E): 1/5, Price-to-Book (P/B): 2/5.

This suggests the company faces some financial challenges worth monitoring. Rating as of 2025-05-19.

D+
Overall Rating
2025-05-19
Overall Score
1/5
DCF Score
1/5
Return on Equity
1/5
Return on Assets
1/5
Debt to Equity
1/5
Price / Earnings
1/5
Price / Book
2/5

Rating History

Date Rating DCF ROE ROA D/E P/E P/B
2025-05-19 D+ 1/5 1/5 1/5 1/5 1/5 2/5
2025-05-16 D+ 1/5 1/5 1/5 1/5 1/5 2/5
2025-05-15 D+ 1/5 1/5 1/5 1/5 1/5 2/5
2025-05-14 D+ 1/5 1/5 1/5 1/5 1/5 2/5
2025-05-13 D+ 1/5 1/5 1/5 1/5 1/5 2/5
2025-05-12 D+ 1/5 1/5 1/5 1/5 1/5 2/5
2025-05-09 D+ 1/5 1/5 1/5 1/5 1/5 2/5
2025-05-08 D+ 1/5 1/5 1/5 1/5 1/5 2/5
2025-05-07 D+ 1/5 1/5 1/5 1/5 1/5 2/5
2025-05-06 D+ 1/5 1/5 1/5 1/5 1/5 2/5
2025-05-05 D+ 1/5 1/5 1/5 1/5 1/5 2/5
2025-05-02 D+ 1/5 1/5 1/5 1/5 1/5 2/5
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message